Literature DB >> 1977532

Comparison of medical and surgical therapy for uncomplicated descending aortic dissection.

D D Glower1, J I Fann, R H Speier, L Morrison, W D White, L R Smith, J S Rankin, D C Miller, W G Wolfe.   

Abstract

To guide the choice of medical versus surgical therapy for patients with descending (type B) aortic dissection (tear in the descending aorta without involvement of the ascending aorta), multivariate survival analysis was applied to 136 patients admitted to two medical centers between 1975 and 1988 with acute (n = 89) or chronic (n = 47) descending dissection: group 1, all 136 patients; group 2, 106 patients without rupture, pulse loss, or visceral organ compromise; and group 3, 56 patients from group 2 without major cardiac or renal disease (23 surgical and 33 medical). Group 3 medical and surgical subgroups were well matched for baseline characteristics and were potential candidates for either mode of therapy. By Cox model analysis, significant predictors of mortality were pleural rupture, other dissection complications, increasing age, and cardiac disease (all p less than 0.01). Surgical versus medical therapy was not an independent determinant of survival in any of the three groups for acute or chronic dissection. Survival probabilities for all group 3 patients at 1, 5, and 10 years were 0.94, 0.87, and 0.32 (medical) and 0.90, 0.80, and 0.50 (surgical). Despite the limitations of this retrospective study (including the possibility of undefined treatment selection biases), these data suggest that medical or early surgical therapy is associated with equivalent outcome in selected patients with uncomplicated acute or chronic descending aortic dissection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1977532

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  14 in total

1.  Right axillary arterial perfusion for a ruptured type B aortic dissection: report of a case.

Authors:  T Katoh; H Gohra; K Hamano; H Noda; Y Fujimura; N Zempo; K Esato
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  Acute Aortic Dissection.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-06

3.  Preliminary report on a sonographic method to determine the location of the intimal breach in Stanford type B aortic dissection.

Authors:  Jingdong Tang; Yuqi Wang; Wenzhao Hang; Weiguo Fu; Zaiping Jing
Journal:  Int J Cardiovasc Imaging       Date:  2010-06-29       Impact factor: 2.357

Review 4.  Acute aortic syndrome: pathology and therapeutic strategies.

Authors:  F Ahmad; N Cheshire; M Hamady
Journal:  Postgrad Med J       Date:  2006-05       Impact factor: 2.401

5.  Endovascular treatment of thoracic dissection.

Authors:  H Rousseau; O Cosin; B Marcheix; V Chabbert; M Midulla; C Dambrin; C Cron; B Leobon; C Conil; P Massabuau; P Otal; F Joffre
Journal:  Semin Intervent Radiol       Date:  2007-06       Impact factor: 1.513

6.  Endovascular management of acute aortic syndromes.

Authors:  Parag J Patel; William Grande; Robert A Hieb
Journal:  Semin Intervent Radiol       Date:  2011-03       Impact factor: 1.513

Review 7.  Open surgical repair for chronic type B aortic dissection: a systematic review.

Authors:  David H Tian; Ramesh P De Silva; Tom Wang; Tristan D Yan
Journal:  Ann Cardiothorac Surg       Date:  2014-07

8.  Long-term outcomes in thoracoabdominal aortic aneurysm repair for chronic type B dissection.

Authors:  Mohamad Bashir; Matthew Shaw; Matthew Fok; Deborah Harrington; Mark Field; Manoj Kuduvalli; Aung Oo
Journal:  Ann Cardiothorac Surg       Date:  2014-07

9.  Predictors of surgical indications for acute type B aortic dissection based on enlargement of aortic diameter during the chronic phase.

Authors:  Hideyuki Kunishige; Kazuhiro Myojin; Yoshimitsu Ishibashi; Koji Ishii; Masakazu Kawasaki; Junichi Oka
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-11

10.  Optimal management of acute aortic dissection.

Authors:  Venu Menon; Jay Sengupta; Samuel Unzek
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.